Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9240391rdf:typepubmed:Citationlld:pubmed
pubmed-article:9240391lifeskim:mentionsumls-concept:C0124604lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0946707lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0254837lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C2004454lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0597360lld:lifeskim
pubmed-article:9240391lifeskim:mentionsumls-concept:C0599668lld:lifeskim
pubmed-article:9240391pubmed:issue7lld:pubmed
pubmed-article:9240391pubmed:dateCreated1997-9-25lld:pubmed
pubmed-article:9240391pubmed:abstractTextPrevious studies have suggested that target-derived nerve growth factor (NGF) is essential for the survival of cholinergic basal forebrain neurons. Thus, axotomy of septohippocampal neurons in adult rats resulting in the withdrawal of target-derived NGF caused a dramatic loss of choline acetyltransferase (ChAT)-immunoreactive neurons in the medial septum-diagonal band complex. We have recently shown that this loss of immunolabelled neurons does not indicate cell death, since many septohippocampal cholinergic neurons recover their immunoreactivity for ChAT after a long survival time despite disconnection from target-derived neurotrophins. One possibility would be that these surviving ChAT-immunoreactive neurons have gained access to other, probably local, NGF sources. Here we provide evidence that the recovery of ChAT immunoreactivity after axotomy is not accompanied by a similar recovery of NGF receptor expression in these neurons. In situ hybridization for p75NTR mRNA and trkA mRNA 6 months after bilateral fimbria-fornix transection revealed a substantial loss of labelled cells. In addition, there was a persisting loss of p75NTR-immunoreactive and NGF-immunoreactive medial septal neurons. Cholinergic neurons in controls did not express NGF mRNA, but were heavily immunostained for NGF protein due to receptor-mediated uptake. These data suggest that at least some cholinergic septohippocampal neurons re-express ChAT either independently of NGF or with a reduced need for NGF.lld:pubmed
pubmed-article:9240391pubmed:languageenglld:pubmed
pubmed-article:9240391pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9240391pubmed:citationSubsetIMlld:pubmed
pubmed-article:9240391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9240391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9240391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9240391pubmed:statusMEDLINElld:pubmed
pubmed-article:9240391pubmed:monthJullld:pubmed
pubmed-article:9240391pubmed:issn0953-816Xlld:pubmed
pubmed-article:9240391pubmed:authorpubmed-author:FrotscherMMlld:pubmed
pubmed-article:9240391pubmed:authorpubmed-author:NaumannTTlld:pubmed
pubmed-article:9240391pubmed:authorpubmed-author:StraubeAAlld:pubmed
pubmed-article:9240391pubmed:issnTypePrintlld:pubmed
pubmed-article:9240391pubmed:volume9lld:pubmed
pubmed-article:9240391pubmed:ownerNLMlld:pubmed
pubmed-article:9240391pubmed:authorsCompleteYlld:pubmed
pubmed-article:9240391pubmed:pagination1340-9lld:pubmed
pubmed-article:9240391pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:meshHeadingpubmed-meshheading:9240391-...lld:pubmed
pubmed-article:9240391pubmed:year1997lld:pubmed
pubmed-article:9240391pubmed:articleTitleRecovery of ChAT immunoreactivity in axotomized rat cholinergic septal neurons despite reduced NGF receptor expression.lld:pubmed
pubmed-article:9240391pubmed:affiliationInstitute of Anatomy, University of Freiburg, Germany.lld:pubmed
pubmed-article:9240391pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9240391pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9240391lld:pubmed